7. Preparing Providers to Consider PrEP (Pre-Exposure Prophylaxis For Hiv) Through a Best Practice Advisory in a Large Academic-Community Pediatric Network

Nationally, about 40% of new HIV diagnoses are among adolescents and young adults. Pre-exposure prophylaxis (PrEP) is a daily medication that was recently FDA-approved for adolescents to reduce the risk of HIV acquisition by over 99%. However, many providers are not yet aware of PrEP. There is an urgent need for youth-focused PrEP programs to train pediatric and adolescent providers. Therefore, we designed and implemented a best practice advisory (BPA) to prompt pediatric providers to consider PrEP for patients at risk for HIV.
Source: Journal of Adolescent Health - Category: Child Development Authors: Source Type: research